Chemours Co
CC- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- SEC CIK
- 0001627223
In the last 90 days, Chemours Co insiders filed 7 open-market purchases and 0 sales; 474 institutions reported holding it in 13F filings for Q2 2026, worth $2.79B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Chemours Co changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 518 | 9 | 487 | −22 |
| Shares | 110.8M | 53.1K | 110.3M | −470.8K (−0.4%) |
| Value | $3.55B | $1.82M | $2.72B | −$825.1M (−23.3%) |
9 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Chemours Co at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (68)
Institutions that held Chemours Co at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (9)
Institutions that held Chemours Co at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sheets Smith Investment Management | 24,813 | $912.0K |
| HYA Advisors, Inc | 10,699 | $343.0K |
| Advisor Partners LLC | 8,344 | $267.0K |
| Ern LLC | 7,000 | $224.0K |
| Brewin Dolphin Ltd | 1,296 | $41.0K |
| Cordasco Financial Network | 412 | $13.0K |
| Fieldpoint Private Securities, LLC | 415 | $13.0K |
| Exane Derivatives | 52 | $1.67K |
| Private Capital Group, LLC | 29 | $1.00K |